BiomeSense is a pioneering life sciences startup focused on harnessing the power of the gut microbiome to revolutionize personalized medicine. With our breakthrough technologies GutLab and MetaBiome, we are setting new standards in microbiome data analysis and interpretation, enabling unprecedented insights to understand & leverage the microbiome for human health.
| Website | http://www.biomesense.com |
| Employees | 17 (12 on RocketReach) |
| Founded | 2018 |
| Address | 2242 W Harrison St 201, Chicago, Illinois 60612, US |
| Industry | Biotechnology, Artificial Intelligence, Data and Analytics, Science and Engineering, Software, Life Science, Medical, Health Care |
| Keywords | Gut Microbiome, Personalized Medicine, Microbiome Testing, Life Sciences, Biotechnology, Gut Health, Precision Medicine, Microbiome Research, Diagnostic Testing, Health Technology, Digital Health, Therapeutics, Scientific Research, Biomarkers, Data Analytics, Clinical Trials, Drug Discovery, Medical Technology |
| Competitors | Thermo Fisher Scientific, Agilent Technologies, BD, Illumina, PerkinElmer, Inc., Merck Group, QIAGEN, BioLegend, Eppendorf Group, MilliporeSigma +38 more (view full list) |
Looking for a particular BiomeSense employee's phone or email?
Kevin Honaker is the CEO of BiomeSense.
12 people are employed at BiomeSense.
BiomeSense is based in Chicago, Illinois.